经过评估,专家小组认为,在预期的使用条件下,不能排除通过饮食接触引起过敏反应的风险,但这种情况发生的可能性很低。在缺乏适当毒理学研究的情况下,评估小组无法就这种食品酶的安全性得出结论。部分原文报道如下:
The food enzyme containing cellulase (4-(1,3;1,4)-β-d-glucan-4-glucanohydrolase; EC 3.2.1.4), endo-1,3(4)-β-glucanase (3-(1,3;1,4)-β-d-glucan 3(4)-glucanohydrolase; EC 3.2.1.6) and endo-1,4-β-xylanase (4-β-d-xylan xylanohydrolase; EC 3.2.1.8) activities is produced with the non-genetically modified Trichoderma reesei strain NZYM-TV by Novozymes A/S. The food enzyme was considered free from viable cells of the production organism. It is intended to be used in nine food manufacturing processes. Since residual amounts of food enzyme–total organic solids (TOS) are removed in two processes, dietary exposure was calculated for the remaining seven food manufacturing processes. It was estimated to be up to 0.177 mg TOS/kg body weight per day in European populations. The Ames test and the repeated dose 90-day oral toxicity study were carried out with a food enzyme containing endo-1,4-β-xylanase and xylan 1,4-β-xylosidase activities, produced with the genetically modified T. reesei strain NZYM-UH. The Panel considered these substitute studies not suitable for the toxicological assessment. The Panel could thus not conclude on genotoxicity and the systemic toxicity due to the absence of studies with the food enzyme under assessment. A search for the homology of each amino acid sequence of the food enzyme to known allergens was made and no match was found. The Panel considered that a risk of allergic reactions upon dietary exposure cannot be excluded, but that the likelihood is low. In the absence of suitable toxicological studies, the Panel cannot conclude on the safety of the food enzyme containing cellulase, endo-1,3(4)-β-glucanase and endo-1,4-β-xylanase activities from the non-genetically modified Trichoderma reesei strain NZYM-TV.
本文由食品伙伴网食品资讯中心编辑,供网友参考,有任何疑问,请联系news@foodmate.net。